Chengjun Wang
Jinan, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 11 publications
Cost-effectiveness of first-line osimertinib plus chemotherapy versus amivantamab plus lazertinib for advanced EGFR-mutant NSCLC in the US and China.
Journal: Therapeutic advances in medical oncology
Published: February 27, 2026
Advances in Covalent-Organic Frameworks for Photocatalysis and Electrocatalysis.
Journal: Langmuir : the ACS journal of surfaces and colloids
Published: December 11, 2025
Exploration of the Gas Adsorption/Selection Behavior and Its Doping Regulation Strategy of COFs for Improved Gas-Sensing Performance.
Journal: ACS sensors
Published: November 25, 2025
A Case of Metastatic Non-small Cell Lung Cancer with Rare BRAF p.L485_T488delinsF Mutation Treated with Dabrafenib and Trametinib
Journal: Zhongguo fei ai za zhi = Chinese journal of lung cancer
Published: October 29, 2025
Clinical outcomes and safety of continuous immunotherapy beyond progression in patients with extensive-stage small cell lung cancer: a retrospective real-world study.
Journal: Frontiers in immunology
Published: August 07, 2025
What is the best first-line combination regimen for advanced EGFR-mutated non-small cell lung cancer: a network meta-analysis and systemic review.
Journal: Frontiers in pharmacology
Published: February 06, 2025
Efficacy and safety of immunotherapy or antiangiogenic agent-based treatment strategies versus chemotherapy as first-line treatment for extensive-stage small cell lung cancer: a network meta-analysis.
Journal: Frontiers in pharmacology
Published: December 04, 2024
Efficacy and patient-reported outcomes in advanced non-small cell lung cancer patients receiving aumolertinib as first-line therapy: a real-world study.
Journal: Frontiers in pharmacology
Published: June 06, 2024
The efficacy and safety of a novel PD-1/CTLA-4 bispecific antibody cadonilimab (AK104) in advanced non-small cell lung cancer: A multicenter retrospective observational study.
Journal: Thoracic cancer
Published: May 30, 2024
Efficacy and safety of novel immune checkpoint inhibitor-based combinations versus chemotherapy as first-line treatment for patients with extensive-stage small cell lung cancer: A network meta-analysis.
Journal: Thoracic cancer
Published: February 22, 2024
Showing 1-11 of 11
Last Updated: 09/26/2026